The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Microbix Biosystems Inc

TSX: MBX
Delayed quote

$0.38

Today's change+0.01 +2.70%
Updated September 22 11:06 AM EDT. Delayed by at least 15 minutes.
 

Microbix Biosystems Inc

TSX: MBX
Delayed quote

$0.38

Today's change+0.01 +2.70%
Updated September 22 11:06 AM EDT. Delayed by at least 15 minutes.

Microbix Biosystems Inc up sharply

Microbix Biosystems Inc closed up sharply Friday, rallying $0.01 or 2.70% to $0.38. Shares have lost 3.80% over the last five days, but have gained 49.02% over the last year to date. This security has outperformed the S&P TSX by 72.30% during the last year.

Key company metrics

  • Trailing P/ENegative, not meaningful
  • P/E 1 year forwardNegative, not meaningful
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend--
  • Dividend yield--
  • Trailing EPS-$0.02
Updated September 22 11:06 AM EDT. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
-17.59%

Although this company's net profit margin is negative, it is above the industry average and implies that Microbix Biosystems Inc is operating more effectively than other companies in the industry.
Company Books

S&P TSX0.00%Sector:HealthcareIndustry:Biotechnology

Latest Company News

Latest Press Releases

View more Press Releases
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q3/2017Q2/2017Q1/2017Q4/2016
Fiscal Quarter Endvalues in $ millions unless otherwise notedJun 30, 201706/30/2017Mar 31, 201703/31/2017Dec 31, 201612/31/2016Sep 30, 201609/30/2016
Revenue3323
Total other revenue--------
Total revenue3323
Gross profit1112
Total cost of revenue1111
Total operating expense3353
Selling / general / administrative1111
Research & development0000
Depreciation / amortization0000
Interest expense (income), net operating0000
Unusual expense (income)003--
Other operating expenses, total0000
Operating income00-31
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets--------
Other--------
Income before tax00-31
Income after tax00-31
Income tax, total0000
Net income00-31
Total adjustments to net income--------
Net income before extra. items00-31
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items00-31
Inc. avail. to common incl. extra. items00-31
Diluted net income00-31
Dilution adjustment----00
Diluted weighted average shares85858585
Diluted EPS excluding extraordinary itemsvalue per share0.000.00-0.040.01
Dividends per sharevalue per share0.000.000.000.00
Diluted normalized EPSvalue per share0.000.00-0.020.01